Abstract:
Disclosed herein are methods of and systems for predicting recurrence of atrial fibrillation comprising protease and protease inhibitor profiling. An exemplary method comprises: measuring MMP-9, MMP-3, and TIMP-4 levels in a body fluid from a subject with a history of atrial fibrillation to produce an MMP/TIMP profile; and using the MMP/TIMP profile to determine whether the subject will have a recurrence of atrial fibrillation following a cardioversion procedure.
Abstract:
Disclosed herein are methods of and systems for predicting recurrence of atrial fibrillation comprising protease and protease inhibitor profiling.
Abstract:
Disclosed herein are methods of and systems for predicting recurrence of atrial fibrillation comprising protease and protease inhibitor profiling. The levels of matrix metalloproteinases (MMPs) and/or tissue inhibitor metalloproteinases (TIMPs) are analyzed to predict the recurrence of atrial fibrillation, and further to predict whether cardioversion will provide a successful therapy.
Abstract:
Disclosed herein are methods of and systems for predicting recurrence of atrial fibrillation comprising protease and protease inhibitor profiling.